German Health Min pressed for reform

29 July 2001

Germany's Health Minister, Ulla Schmidt, is coming under increasingpressure over the government's health service reforms, as the controversy surrounding the direction this should take intensifies.

The Social Democratic Party has called for a major reform blueprint and media reports have suggested that Ms Schmidt's advisers are pushing her in that direction. However, the Minister has said merely that the structure of the service needs to be changed.

Freidrich Schwartz, chairman of a technical advisory group within the Ministry, has said in a newspaper article that, despite numerous legal and regulatory interventions, the health service urgently needs reform. He pointed out that the state had to intervene more forcefully to determine, for example, the number and qualifications of medical general practitioners. Mr Schwartz warned over the danger of too much competition and said that successful European neighbors all demonstrated stronger control of health care.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight